CompoAtlas

TENOSAN PRO

Food supplement declared in France, declaration No 2016-7-843

TENOSAN PRO is a food supplement declared in France. Status: retiré du marché le 29 November 2023. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
AGAVE S.R.L.
Status
Retiré du marché le 29 November 2023
Form
Sachet
Daily dose
1 à 2 sachets par jour
Directions for use
dissoudre le contenu des sachets dans un verre d'eau, bien mélanger et boire immédiatement
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Articulations, Circulation sanguine et lymphatique

Declaration 156298, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Malus domestica BorkhFruitExtrait sec hydroalcoolique50 mg
Vitis vinifera L.PépinExtrait sec hydroalcoolique50 mg

Other active ingredients

NamePer day
L-Arginine-alpha-cétoglutaratenot declared
Méthylsulfonate de méthanenot declared
Collagène hydrolysénot declared
Bromélaïnenot declared
Gamma-cyclodextrinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E330, E162, E955, E551

Other ingredients

maltodextrine, huile de palme

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line